Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

주식 순위 #2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
주가
$100.60
시가총액
$7.54B
변동 (1일)
-1.49%
변동 (1년)
49.53%
국가
CH
거래 Bachem Holding AG (BANB)

카테고리

Healthcare
Bachem Holding AG (BANB)의 P/B 비율
October 2026 기준 P/B 비율 TTM: 4.31
Bachem Holding AG의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 4.31입니다. 2024년 말 기준 P/B 비율은 3.12였습니다.
Bachem Holding AG의 P/B 비율 기록 (2002 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
2026 (TTM) 4.31 40.03%
2025 3.08 -1.34%
2024 3.12 -15.11%
2023 3.68 -26.96%
2022 5.03 -44.38%
2021 9.05 -22.23%
2020 11.64 143.30%
2019 4.78 18.05%
2018 4.05 -27.47%
2017 5.59 66.84%
2016 3.35 68.44%
2015 1.99 4.79%
2014 1.90 -2.54%
2013 1.95 29.71%
2012 1.50 14.42%
2011 1.31 -37.56%
2010 2.10 -11.45%
2009 2.37 -17.55%
2008 2.88 -18.65%
2007 3.54 13.43%
2006 3.12 -76.81%
2005 13.44 424.43%
2004 2.56 2,367.37%
2003 0.10 11,444.44%
2002 0.00 0.00%
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
6.251 44.93%
US
13.2547 207.32%
US
4.4521 3.23%
AU
6.3632 47.54%
NL
- -
CH